HIMS Long target 73 $After retesting 3 times a fib fan resistence, i think it will break very strong this time
and it will bounce much higher.
Then, on weekly timeframe, it seems a nice cup and handle pattern,
for this reason i hope it will go higher in medium-long term
First target: 73 $
Second target: 90 $
Third ta
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
16.51 MXN
2.63 B MXN
30.78 B MXN
202.54 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
ISIN
US4330001060
FIGI
BBG01PDTP356
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Related stocks
Hims breakoutHims looks to break out deeper into the weekly supply zone on this push. With massive short interest and retail hype, it will likely at least have a lot of attention. OBV wedge looks for a breakout to the upside, and we just saw a blue flash on BBWP (volatility). I would not be looking for profits u
Hims long into supplyHims has decided to push the supply as we previously mentioned. We note a breakout of the OBV, which I have been tracking (momentum). As I previously stated, I was looking for a push to 60 again. Volatility has reset, and shorts are being squeezed. I would like to think that 51-ish is the new range,
$HIMS weekend analysis - 21st September, 2025Last week’s news-driven dip to the 48–49 range turned into a solid buying opportunity - the quick recovery shows it was more noise than substance. With the strong bounce, price looks set to retest the key 62.3 - 64.9 resistance zone, which could be the target for this week.
If we get a daily close
Don't Hold a Bag, HIMSHello I am the Cafe Trader.
Today we’re looking again at the hyped HIMS (Hims & Hers Health).
This is a wide range, make sure you get good pricing if you add to the long term.
Price is currently sitting right above Strong Buyers These buyers are holding, and the shorts may be exhausting havi
HIMS LONG Swing Entry PlanNYSE:HIMS LONG Swing Entry Plan
Entry Zone 1: $46.10 – $46.50
→ Open initial position targeting +8% from entry level.
Entry Zone 2: $43.00 – $43.20
→ If price dips further, average down with a second equal-sized entry.
→ New target becomes +8% from the average of Entry 1 and Entry 2.
AD Zone
Hims & Hers Health, Inc. NYSE- (W)-institutional participationPrice has bounced back from recent pullbacks and is now approaching a key resistance zone near $65.85 (previous highs marked in red).
Above $65.85, the next Fibonacci extensions point toward $76.15, $86.04, and $95.94 as potential upside targets.
Volume
The recent green candles are supported by h
Super Performance CandidateNYSE:HIMS , explosive revenue and subscriber growth; already exceeding guidance, dominance in high growth telehealth and lifestyle drug markets with relentless innovation
At a RS Rating of 98,
I have reasons to believe that this equity can increase in price
(Now in white chart canvas!)
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HIMS is 1,063.00 MXN — it has decreased by −0.33% in the past 24 hours. Watch Hims & Hers Health, Inc. Class A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange Hims & Hers Health, Inc. Class A stocks are traded under the ticker HIMS.
HIMS stock has risen by 6.30% compared to the previous week, the month change is a 32.05% rise, over the last year Hims & Hers Health, Inc. Class A has showed a 234.28% increase.
We've gathered analysts' opinions on Hims & Hers Health, Inc. Class A future price: according to them, HIMS price has a max estimate of 1,560.49 MXN and a min estimate of 514.04 MXN. Watch HIMS chart and read a more detailed Hims & Hers Health, Inc. Class A stock forecast: see what analysts think of Hims & Hers Health, Inc. Class A and suggest that you do with its stocks.
HIMS reached its all-time high on Feb 19, 2025 with the price of 1,515.99 MXN, and its all-time low was 283.00 MXN and was reached on Sep 9, 2024. View more price dynamics on HIMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HIMS stock is 3.85% volatile and has beta coefficient of 2.62. Track Hims & Hers Health, Inc. Class A stock price on the chart and check out the list of the most volatile stocks — is Hims & Hers Health, Inc. Class A there?
Today Hims & Hers Health, Inc. Class A has the market capitalization of 239.42 B, it has decreased by −3.47% over the last week.
Yes, you can track Hims & Hers Health, Inc. Class A financials in yearly and quarterly reports right on TradingView.
Hims & Hers Health, Inc. Class A is going to release the next earnings report on Nov 10, 2025. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are 3.19 MXN per share, whereas the estimation was 2.83 MXN resulting in a 12.73% surprise. The estimated earnings for the next quarter are 1.76 MXN per share. See more details about Hims & Hers Health, Inc. Class A earnings.
Hims & Hers Health, Inc. Class A revenue for the last quarter amounts to 10.22 B MXN, despite the estimated figure of 10.35 B MXN. In the next quarter, revenue is expected to reach 10.64 B MXN.
HIMS net income for the last quarter is 797.32 M MXN, while the quarter before that showed 1.01 B MXN of net income which accounts for −21.35% change. Track more Hims & Hers Health, Inc. Class A financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 23, 2025, the company has 1.64 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. Class A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. Class A EBITDA is 3.11 B MXN, and current EBITDA margin is 5.76%. See more stats in Hims & Hers Health, Inc. Class A financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. Class A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hims & Hers Health, Inc. Class A technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hims & Hers Health, Inc. Class A stock shows the neutral signal. See more of Hims & Hers Health, Inc. Class A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.